Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASSIC: Tavneos in ANCA-associated vasculitis
NCT02222155Phase 2Completed
- Sponsor
- Amgen
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of avacopan in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by Amgen. Started Feb 2015; status: completed.
02
Drugs
avacopan
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT02222155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222155.